PERP B Stock Overview
Provides products and solutions for use of injectable drugs in Sweden.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Perpetua Medical AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr0.083 |
| 52 Week High | kr0.51 |
| 52 Week Low | kr0.02 |
| Beta | 2.28 |
| 1 Month Change | -13.75% |
| 3 Month Change | 12.20% |
| 1 Year Change | -82.75% |
| 3 Year Change | -99.07% |
| 5 Year Change | -99.43% |
| Change since IPO | -99.54% |
Recent News & Updates
Recent updates
Shareholder Returns
| PERP B | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | -17.2% | -0.3% | -1.3% |
| 1Y | -82.8% | -7.9% | 13.4% |
Return vs Industry: PERP B underperformed the Swedish Medical Equipment industry which returned -7.9% over the past year.
Return vs Market: PERP B underperformed the Swedish Market which returned 13.4% over the past year.
Price Volatility
| PERP B volatility | |
|---|---|
| PERP B Average Weekly Movement | 15.4% |
| Medical Equipment Industry Average Movement | 7.1% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in SE Market | 12.9% |
| 10% least volatile stocks in SE Market | 3.5% |
Stable Share Price: PERP B's share price has been volatile over the past 3 months.
Volatility Over Time: PERP B's weekly volatility has decreased from 24% to 15% over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 10 | Anders Hedlund | pharmacolog.com |
Perpetua Medical AB (publ) provides products and solutions for use of injectable drugs in Sweden. The company offers DrugLog, a solution for reducing medication errors in pharmacy; WasteLog, a device that analysis waste and returns of injectable controlled substances; and PrepLog, a DrugLog based technology platform that integrated prescription software or medication management system for the test of drug preparations. The company formerly known as Pharmacolog i Uppsala AB (publ) and changed its name to Perpetua Medical AB (publ) in April 2024.
Perpetua Medical AB (publ) Fundamentals Summary
| PERP B fundamental statistics | |
|---|---|
| Market cap | kr8.99m |
| Earnings (TTM) | -kr11.98m |
| Revenue (TTM) | kr12.89m |
0.7x
P/S Ratio-0.8x
P/E RatioIs PERP B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PERP B income statement (TTM) | |
|---|---|
| Revenue | kr12.89m |
| Cost of Revenue | kr2.77m |
| Gross Profit | kr10.11m |
| Other Expenses | kr22.09m |
| Earnings | -kr11.98m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 23, 2024
| Earnings per share (EPS) | -0.11 |
| Gross Margin | 78.48% |
| Net Profit Margin | -92.97% |
| Debt/Equity Ratio | 0% |
How did PERP B perform over the long term?
See historical performance and comparison